Fact · Dictation software
139million US dollars
On July 19, 2024, Augmedix agreed to be acquired by Commure, Inc. in an all-cash transaction that values Augmedix at approximately $139 million in equity value.
Quote found word for word on the live source, last checked October 20, 2026
In the source's own words
“in an all-cash transaction that values Augmedix at approximately $139 million in equity value”
Augmedix to Join Forces with Commure, Augmedix, Inc., Augmedix, Inc. press release (GlobeNewswire), July 19, 2024, 2024, Press release, first paragraph.
Open the original- What it measures
- Augmedix describes itself as a leader in ambient AI medical documentation and data solutions. Commure is the buyer. Under the agreement, Augmedix stockholders receive $2.35 per share in cash, and Commure acquires all outstanding shares for a total equity value of approximately $139 million.
- What it does not show
- This is the price paid for the company's shares, not a funding round and not a valuation of a round. The release says approximately and was published before the deal closed, so the final amount may differ.
In the data
A row of Voice AI Funding: Speech and Dictation Startup Rounds, as Augmedix acquired by Commure: 139 million US dollars.
- Company
- Augmedix
- Deal
- Acquisition
- What the company makes
- Medical scribe or dictation
- Led by or buyer
- Commure, Inc.
- Announced
- 2024-07-19
- Year
- 2024
Source
Used to calculate
- In the funding rounds and acquisitions in speech recognition and dictation dataset, the 8 published figures for “Medical scribe or dictation” have a median of 75 million US dollars, ranging from 4.2 to 19,700.
- The funding rounds and acquisitions in speech recognition and dictation dataset holds 54 data points, each a published figure traced to its source.
- The funding rounds and acquisitions in speech recognition and dictation dataset draws on 50 distinct sources.